Massimo Catarini

665 total citations
30 papers, 465 citations indexed

About

Massimo Catarini is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Massimo Catarini has authored 30 papers receiving a total of 465 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Hematology, 17 papers in Molecular Biology and 17 papers in Oncology. Recurrent topics in Massimo Catarini's work include Multiple Myeloma Research and Treatments (18 papers), Protein Degradation and Inhibitors (11 papers) and Cancer Treatment and Pharmacology (8 papers). Massimo Catarini is often cited by papers focused on Multiple Myeloma Research and Treatments (18 papers), Protein Degradation and Inhibitors (11 papers) and Cancer Treatment and Pharmacology (8 papers). Massimo Catarini collaborates with scholars based in Italy, Brazil and Poland. Massimo Catarini's co-authors include Massimo Offidani, Laura Corvatta, Francesco Alesiani, Marino Brunori, Pietro Leoni, Giuseppe Visani, Riccardo Centurioni, Attilio Olivieri, Mauro Montanari and Anna Mele and has published in prestigious journals such as Blood, British Journal of Haematology and The Oncologist.

In The Last Decade

Massimo Catarini

29 papers receiving 457 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Massimo Catarini Italy	14	298	230	207	71	66	30	465
Elif Suyanı Türkiye	11	165 0.6×	117 0.5×	77 0.4×	43 0.6×	28 0.4×	41	381
Johannes Meran Austria	8	127 0.4×	80 0.3×	120 0.6×	19 0.3×	52 0.8×	45	285
Babak Bahar Iran	10	256 0.9×	91 0.4×	182 0.9×	36 0.5×	91 1.4×	37	438
David Hughes United States	7	45 0.2×	96 0.4×	49 0.2×	27 0.4×	58 0.9×	32	324
Grace H. Tang Canada	11	83 0.3×	128 0.6×	90 0.4×	9 0.1×	24 0.4×	42	364
Corina J. van den Hurk Netherlands	8	55 0.2×	377 1.6×	33 0.2×	19 0.3×	25 0.4×	8	583
Anabela Cardoso United States	8	117 0.4×	78 0.3×	38 0.2×	46 0.6×	14 0.2×	18	481
E Lobato-Mendizábal Mexico	8	135 0.5×	43 0.2×	37 0.2×	24 0.3×	118 1.8×	27	291
Wayne A. Bottner United States	9	71 0.2×	124 0.5×	23 0.1×	137 1.9×	29 0.4×	18	297
Anne‐Barbara Mongey United States	12	65 0.2×	20 0.1×	38 0.2×	58 0.8×	37 0.6×	21	455

Countries citing papers authored by Massimo Catarini

Since Specialization

Citations

This map shows the geographic impact of Massimo Catarini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Massimo Catarini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Massimo Catarini more than expected).

Fields of papers citing papers by Massimo Catarini

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Massimo Catarini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Massimo Catarini. The network helps show where Massimo Catarini may publish in the future.

Co-authorship network of co-authors of Massimo Catarini

This figure shows the co-authorship network connecting the top 25 collaborators of Massimo Catarini. A scholar is included among the top collaborators of Massimo Catarini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Massimo Catarini. Massimo Catarini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Valentini, Elisabetta, Valter Giantin, Alberto Voci, et al.. (2014). Artificial Nutrition and Hydration in Terminally Ill Patients with Advanced Dementia: Opinions and Correlates among Italian Physicians and Nurses. Journal of Palliative Medicine. 17(10). 1143–1149. 16 indexed citations

Offidani, Massimo, Claudia Polloni, Federica Cavallo, et al.. (2012). Phase II study of melphalan, thalidomide and prednisone combined with oral panobinostat in patients with relapsed/refractory multiple myeloma. Leukemia & lymphoma. 53(9). 1722–1727. 41 indexed citations

Offidani, Massimo, Laura Corvatta, Claudia Polloni, et al.. (2012). Assessment of Vulnerability Measures and Their Effect on Survival in a Real-Life Population of Multiple Myeloma Patients Registered at Marche Region Multiple Myeloma Registry. Clinical Lymphoma Myeloma & Leukemia. 12(6). 423–432. 36 indexed citations

Offidani, Massimo, Laura Corvatta, Claudia Polloni, et al.. (2011). Infectious complications in patients with multiple myeloma treated with new drug combinations containing thalidomide. Leukemia & lymphoma. 52(5). 776–785. 17 indexed citations

Offidani, Massimo, Laura Corvatta, Claudia Polloni, et al.. (2011). Thalidomide, dexamethasone, Doxil and Velcade (ThaDD-V) followed by consolidation/maintenance therapy in patients with relapsed–refractory multiple myeloma. Annals of Hematology. 90(12). 1449–1456. 14 indexed citations

Offidani, Massimo, Pietro Leoni, Laura Corvatta, et al.. (2010). ThaDD plus high dose therapy and autologous stem cell transplantation does not appear superior to ThaDD plus maintenance in elderly patients with de novo multiple myeloma. European Journal Of Haematology. 84(6). 474–483. 12 indexed citations

Offidani, Massimo, Laura Corvatta, Claudia Polloni, et al.. (2008). Thalidomide‐dexamethasone versus Interferon‐alpha‐dexamethasone as maintenance treatment after ThaDD induction for multiple myeloma: a prospective, multicentre, randomised study. British Journal of Haematology. 144(5). 653–659. 23 indexed citations

Visani, Giuseppe, Felicetto Ferrara, Francesco Alesiani, et al.. (2008). R-COMP 21 for frail elderly patients with aggressive B-cell non-Hodgkin lymphoma: A pilot study. Leukemia & lymphoma. 49(6). 1081–1086. 34 indexed citations

Offidani, Massimo, Laura Corvatta, Claudia Polloni, et al.. (2008). Serum C-Reactive Protein at Diagnosis and Response to Therapy Is the Most Powerful Factor Predicting Outcome of Multiple Myeloma Treated with Thalidomide/Anthracycline—Based Therapy. Clinical Lymphoma & Myeloma. 8(5). 294–299. 9 indexed citations

10.

Mele, Anna, Massimo Offidani, Giuseppe Visani, et al.. (2007). Technetium‐99m sestamibi scintigraphy is sensitive and specific for the staging and the follow‐up of patients with multiple myeloma: a multicentre study on 397 scans. British Journal of Haematology. 136(5). 729–735. 25 indexed citations

11.

Offidani, Massimo, Claudia Polloni, Laura Corvatta, et al.. (2007). ThaDD-V Treatment for Patients with Relapsed/Refractory Multiple Myeloma: A Feasibility/Activity Study.. Blood. 110(11). 2729–2729. 1 indexed citations

12.

Offidani, Massimo, Laura Corvatta, Giuseppe Visani, et al.. (2006). Low-dose thalidomide with pegylated liposomal doxorubicin and high-dose dexamethasone for relapsed/refractory multiple myeloma: a prospective, multicenter, phase II study.. PubMed. 91(1). 133–6. 62 indexed citations

13.

Offidani, Massimo, Laura Corvatta, Giuseppe Visani, et al.. (2005). Thalidomide, Dexamethasone and Pegylated-Liposomal Doxorubicin (ThaDD) for Untreated Multiple Myeloma Patients Aged over 65 Years.. Blood. 106(11). 2558–2558. 1 indexed citations

14.

Offidani, Massimo, Laura Corvatta, Attilio Olivieri, et al.. (2004). Thalidomide plus oral melphalan compared with thalidomide alone for advanced multiple myeloma. The Hematology Journal. 5(4). 312–317. 21 indexed citations

15.

Offidani, Massimo, Laura Corvatta, Lara Malerba, et al.. (2004). Comparison of two regimens for the treatment of elderly patients with acute lymphoblastic leukaemia (ALL). Leukemia & lymphoma. 46(2). 233–238. 13 indexed citations

16.

Offidani, Massimo, Laura Corvatta, Lara Malerba, et al.. (2004). Common and rare side‐effects of low‐dose thalidomide in multiple myeloma: focus on the dose‐minimizing peripheral neuropathy. European Journal Of Haematology. 72(6). 403–409. 34 indexed citations

17.

Offidani, Massimo, Laura Corvatta, Lara Malerba, et al.. (2004). Comparison of Two Regimens for the Treatment of Elderly Patients with Acute Lymphoblastic Leukaemia (ALL).. Blood. 104(11). 4490–4490. 4 indexed citations

18.

Montillo, Marco, Marina Scarpelli, Giancarlo Discepoli, et al.. (1994). Meningioma-like Cerebral Relapse of Hodgkin's Disease. Leukemia & lymphoma. 14(1-2). 185–187. 1 indexed citations

19.

Grassi, Gabriele, et al.. (1990). Automatic implantable pharmacological defibrillator (AIPHD). Preliminary investigations in animals. 6(3). 1131–1140. 1 indexed citations

20.

Catarini, Massimo. (1988). Hereditary macrothrombocytopenia, deafness, nephropathy.. PubMed. 73(1). 43–7. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact